Plasmacytoid Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-09-16
Clinical Trial Update: BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma [Phase 1]
A Phase 1 trial of a BCMA-CD19 CAR-T cell therapy for relapsed/refractory multiple myeloma and plasmacytoid lymphoma is currently recruiting…